Clinical outcomes of patients with acute lymphoblastic leukemia receiving the hyper-CVAD regimen and assessment of the risk of hepatitis flares due to hepatitis B virus reactivation after chemotherapy

INTRODUCTION: Hyper-CVAD (hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone) has become a popular regimen for adults with acute lymphoblastic leukemia (ALL). We assessed the efficacy and tolerability of hyper-CVAD in the treatment of adult ALL. MATERIAL AND METHODS: We r...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Man Fai, Chan, Hay Nun, Kong, Shun Yin, Lai, Ho Kei, Ha, Chung Yin, Ng, Celia, Yeung, Yiu Ming, Yip, Sze Fai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886409/
https://www.ncbi.nlm.nih.gov/pubmed/35251415
http://dx.doi.org/10.5114/aoms/103606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886409/
https://www.ncbi.nlm.nih.gov/pubmed/35251415
http://dx.doi.org/10.5114/aoms/103606

Ejemplares similares